Low serum magnesium is associated with incident dementia in the ARIC-NCS cohort

Aniqa B. Alam; Pamela L. Lutsey; Rebecca F. Gottesman; Adrienne Tin; Alvaro Alonso

doi:10.3390/nu12103074

Low serum magnesium is associated with incident dementia in the ARIC-NCS cohort

Aniqa B. Alam, Pamela L. Lutsey, Rebecca F. Gottesman, Adrienne Tin, Alvaro Alonso

Epidemiology

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Abstract

Higher serum magnesium is associated with lower risk of multiple morbidities, including diabetes, stroke, and atrial fibrillation, but its potential neuroprotective properties have also been gaining traction in cognitive function and decline research. We studied 12,040 participants presumed free of dementia in the Atherosclerosis Risk in Communities (ARIC) study. Serum magnesium was measured in fasting blood samples collected in 1990–1992. Dementia status was ascertained through cognitive examinations in 2011–2013, 2016–2017, and 2018–2019, along with informant interviews and indicators of dementia-related hospitalization events and death. Participants’ cognitive functioning capabilities were assessed up to five times between 1990–1992 and 2018–2019. The cognitive function of participants who did not attend follow-up study visits was imputed to account for attrition. We identified 2519 cases of dementia over a median follow-up period of 24.2 years. The lowest quintile of serum magnesium was associated with a 24% higher rate of incident dementia compared to those in the highest quintile of magnesium (HR, 1.24; 95% CI, 1.07, 1.44). No relationship was found between serum magnesium and cognitive decline in any cognitive domain. Low midlife serum magnesium is associated with increased risk of incident dementia, but does not appear to impact rates of cognitive decline.

Original language	English (US)
Article number	3074
Pages (from-to)	1-11
Number of pages	11
Journal	Nutrients
Volume	12
Issue number	10
DOIs	https://doi.org/10.3390/nu12103074
State	Published - Oct 2020

Bibliographical note

Funding Information:
Funding: The Atherosclerosis Risk in Communities Study was carried out as a collaborative study, supported by National Heart, Lung, and Blood Institute contracts (HHSN268201700004I, HHSN268201700003I, HHSN268201700002I, HHSN268201700005I, HHSN268201700001I). Neurocognitive data were collected by U01 2U01HL096917, 2U01HL096899, 2U01HL096814, 2U01HL096902, 2U01HL096812 from the NIH (NHLBI, NINDS, NIA and NIDCD), and with previous brain MRI examinations funded by R01-HL70825 from the NHLBI. Additional support was provided by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number K24HL148521. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Publisher Copyright:
© 2020 by the authors. Licensee MDPI, Basel, Switzerland.

Keywords

Cognitive decline
Dementia
Magnesium

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.3390/nu12103074

OpenUrl availability

Full text

Cite this

@article{7f3b58abb24f4d34a3ffa1b040c884f8,

title = "Low serum magnesium is associated with incident dementia in the ARIC-NCS cohort",

abstract = "Higher serum magnesium is associated with lower risk of multiple morbidities, including diabetes, stroke, and atrial fibrillation, but its potential neuroprotective properties have also been gaining traction in cognitive function and decline research. We studied 12,040 participants presumed free of dementia in the Atherosclerosis Risk in Communities (ARIC) study. Serum magnesium was measured in fasting blood samples collected in 1990–1992. Dementia status was ascertained through cognitive examinations in 2011–2013, 2016–2017, and 2018–2019, along with informant interviews and indicators of dementia-related hospitalization events and death. Participants{\textquoteright} cognitive functioning capabilities were assessed up to five times between 1990–1992 and 2018–2019. The cognitive function of participants who did not attend follow-up study visits was imputed to account for attrition. We identified 2519 cases of dementia over a median follow-up period of 24.2 years. The lowest quintile of serum magnesium was associated with a 24% higher rate of incident dementia compared to those in the highest quintile of magnesium (HR, 1.24; 95% CI, 1.07, 1.44). No relationship was found between serum magnesium and cognitive decline in any cognitive domain. Low midlife serum magnesium is associated with increased risk of incident dementia, but does not appear to impact rates of cognitive decline.",

keywords = "Cognitive decline, Dementia, Magnesium",

author = "Alam, {Aniqa B.} and Lutsey, {Pamela L.} and Gottesman, {Rebecca F.} and Adrienne Tin and Alvaro Alonso",

note = "Funding Information: Funding: The Atherosclerosis Risk in Communities Study was carried out as a collaborative study, supported by National Heart, Lung, and Blood Institute contracts (HHSN268201700004I, HHSN268201700003I, HHSN268201700002I, HHSN268201700005I, HHSN268201700001I). Neurocognitive data were collected by U01 2U01HL096917, 2U01HL096899, 2U01HL096814, 2U01HL096902, 2U01HL096812 from the NIH (NHLBI, NINDS, NIA and NIDCD), and with previous brain MRI examinations funded by R01-HL70825 from the NHLBI. Additional support was provided by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number K24HL148521. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Publisher Copyright: {\textcopyright} 2020 by the authors. Licensee MDPI, Basel, Switzerland.",

year = "2020",

month = oct,

doi = "10.3390/nu12103074",

language = "English (US)",

volume = "12",

pages = "1--11",

journal = "Nutrients",

issn = "2072-6643",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "10",

}

TY - JOUR

T1 - Low serum magnesium is associated with incident dementia in the ARIC-NCS cohort

AU - Alam, Aniqa B.

AU - Lutsey, Pamela L.

AU - Gottesman, Rebecca F.

AU - Tin, Adrienne

AU - Alonso, Alvaro

N1 - Funding Information: Funding: The Atherosclerosis Risk in Communities Study was carried out as a collaborative study, supported by National Heart, Lung, and Blood Institute contracts (HHSN268201700004I, HHSN268201700003I, HHSN268201700002I, HHSN268201700005I, HHSN268201700001I). Neurocognitive data were collected by U01 2U01HL096917, 2U01HL096899, 2U01HL096814, 2U01HL096902, 2U01HL096812 from the NIH (NHLBI, NINDS, NIA and NIDCD), and with previous brain MRI examinations funded by R01-HL70825 from the NHLBI. Additional support was provided by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number K24HL148521. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Publisher Copyright: © 2020 by the authors. Licensee MDPI, Basel, Switzerland.

PY - 2020/10

Y1 - 2020/10

N2 - Higher serum magnesium is associated with lower risk of multiple morbidities, including diabetes, stroke, and atrial fibrillation, but its potential neuroprotective properties have also been gaining traction in cognitive function and decline research. We studied 12,040 participants presumed free of dementia in the Atherosclerosis Risk in Communities (ARIC) study. Serum magnesium was measured in fasting blood samples collected in 1990–1992. Dementia status was ascertained through cognitive examinations in 2011–2013, 2016–2017, and 2018–2019, along with informant interviews and indicators of dementia-related hospitalization events and death. Participants’ cognitive functioning capabilities were assessed up to five times between 1990–1992 and 2018–2019. The cognitive function of participants who did not attend follow-up study visits was imputed to account for attrition. We identified 2519 cases of dementia over a median follow-up period of 24.2 years. The lowest quintile of serum magnesium was associated with a 24% higher rate of incident dementia compared to those in the highest quintile of magnesium (HR, 1.24; 95% CI, 1.07, 1.44). No relationship was found between serum magnesium and cognitive decline in any cognitive domain. Low midlife serum magnesium is associated with increased risk of incident dementia, but does not appear to impact rates of cognitive decline.

AB - Higher serum magnesium is associated with lower risk of multiple morbidities, including diabetes, stroke, and atrial fibrillation, but its potential neuroprotective properties have also been gaining traction in cognitive function and decline research. We studied 12,040 participants presumed free of dementia in the Atherosclerosis Risk in Communities (ARIC) study. Serum magnesium was measured in fasting blood samples collected in 1990–1992. Dementia status was ascertained through cognitive examinations in 2011–2013, 2016–2017, and 2018–2019, along with informant interviews and indicators of dementia-related hospitalization events and death. Participants’ cognitive functioning capabilities were assessed up to five times between 1990–1992 and 2018–2019. The cognitive function of participants who did not attend follow-up study visits was imputed to account for attrition. We identified 2519 cases of dementia over a median follow-up period of 24.2 years. The lowest quintile of serum magnesium was associated with a 24% higher rate of incident dementia compared to those in the highest quintile of magnesium (HR, 1.24; 95% CI, 1.07, 1.44). No relationship was found between serum magnesium and cognitive decline in any cognitive domain. Low midlife serum magnesium is associated with increased risk of incident dementia, but does not appear to impact rates of cognitive decline.

KW - Cognitive decline

KW - Dementia

KW - Magnesium

UR - http://www.scopus.com/inward/record.url?scp=85092418046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85092418046&partnerID=8YFLogxK

U2 - 10.3390/nu12103074

DO - 10.3390/nu12103074

M3 - Article

C2 - 33050118

AN - SCOPUS:85092418046

SN - 2072-6643

VL - 12

SP - 1

EP - 11

JO - Nutrients

JF - Nutrients

IS - 10

M1 - 3074

ER -

Low serum magnesium is associated with incident dementia in the ARIC-NCS cohort

Abstract

Bibliographical note

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this